Home
Search

News

Vivamus vulputate bibendum diam id facilisis. Morbi id nisi non mi ullamcorper feugiat. Duis sem ante, rhoncus eu ultrices vitae, vehicula vitae mauris. Donec id aliquet est, quis gravida felis. Suspendisse semper ut dui at semper.
Press Releases
Browse All
Trump Administration and Speaker Pelosi Surrender…
Exclusion of biologics provisions in revised USMCA sets dangerous precedent for future trade talks, including with China Puts American jobs, intellectual property and leadership in medical innovation at risk WASHINGTON – BIO President and CEO Jim…
Learn more
More than 135 Emerging Biotech Leaders Urge…
More than 135 Emerging Biotech Leaders Urge Congress to Reject H.R. 3  “Our continued success depends on maintaining an environment that supports investment in tomorrow’s discoveries.” Washington, DC: December 5, 2019 – In a letter addressed…
Learn more
Speaker Pelosi’s Drug Pricing Plan Could Result…
Washington, D.C. (November 21, 2019) — Speaker Nancy Pelosi’s Lower Drug Costs Now Act of 2019, H.R.3, could result in at least 56 fewer new medicines for patients over 10 years, according to a new analysis from economic…
Learn more
Letters, Testimony, & Comments
Browse All
More than 135 Emerging Biotech Leaders Urge…
In a letter addressed to House Speaker Nancy Pelosi (D-CA) and House Republican Leader Kevin McCarthy (R-CA), 138 emerging biotech leaders warn that H.R. 3, the Lower Drug Cost Now Act, will “shatter the dreams” of patients and families who stand to…
Learn more
BIO Comments on RFS Standards for 2020 and…
BIO's comments on the EPA’s administration of the of the Renewable Fuel Standard (RFS)  program and how it has put the investments made by BIO Member companies at risk and threatens to prevent growth in advanced and cellulosic biofuels as the…
Learn more
BIO Comments on FDA docket Standards for Future…
Biotechnology Innovation Organization (BIO) comments on the FDA docket, Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction. BIO also believes that risks associated with opioid…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Learn more
Blog Posts
Browse all Blogs
This Major Breakthrough Could Help Improve Global Food Supply
GMO Answers Celebrates World Soil Day
December 4, 2019
On December 5,  United Nations World Soil Day 2019 (#WorldSoilDay) and its campaign "Stop soil erosion, Save our future" raises awareness on the importance of sustaining healthy ecosystems …
Welcome to the new bio.org
Welcome to the all-new BIO.org!
November 26, 2019
Welcome to the all-new BIO.org! BIO.org is now your one-stop-shop for everything BIO, from information and resources on our advocacy and policy work, to everything you need to know about BIO events.  For the first…
Patient & Health Advocacy Summit
Patient Storytelling: There’s an Art to it!
November 18, 2019
After 30-plus years working in Washington DC, it’s clear healthcare decision makers recognize that a patient’s story can add value to a discussion when data cannot. While the value of data is not disputed, the art…